Skip to content

Treatment interruption in cure research is associated with greater risk of non-AIDS related events in the long term, Spanish study finds

Dragana Gordic/Shutterstock.com

Untreated HIV, low CD4 count or unsuppressed viral load raise the risk of COVID-19 death in South Africa

IMF Photo/James Oatway. Creative Commons licence.

Major HIV vaccine efficacy trial ends early due to lack of protection for women

Lindsay Mgbor/Department for International Development. Creative Commons licence.

Could gene therapies be used to cure more people with HIV?

Dr Jennifer Adair and Dr Cissy Kityo presenting at IAS 2021.

Fast-track drug refills prove the most common HIV service adaptation in Uganda

Baylor College of Medicine Children's Foundation–Malawi / Robbie Flick. USAID images. Creative Commons licence

US CDC recommends third dose of Pfizer and Moderna COVID-19 vaccines for immunocompromised people

Marco Verch. Creative Commons licence.

A vicious cycle: how food insecurity, violence, poor mental health, and substance use increase HIV’s impact on US Black women

RODNAE Productions/Pexels

Dolutegravir-based regimens result in sustained viral suppression, despite lower adherence and treatment interruptions

A dolutegravir pill

Conclusive PrEP study in China paves the way for national provision for gay men

Michael Moloney/Shutterstock.com